Form D · Biotechnology
3X Genetics Inc.
Worcester, MA · CIK 0002123903
Offering snapshot reported Mar 25, 2026 · SEC filing
- Reported sold
- $3.16M Offering amount: $4M
- Investors reported
- 52 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Aug 5, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 25, 2026 | Initial | $3,159,986 | No comparison | 52 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-577657
Source: Form D, filed Mar 25, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin Donahue | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
17 Briden St
Worcester, MA, 01605
Worcester, MA, 01605